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Genomic RNA encapsidation in lentiviruses is a highly selective and regulated process. The unspliced RNA
molecules are selected for encapsidation from a pool of many different viral and cellular RNA species. Moreover, two
molecules are encapsidated per viral particle, where they are found associated as a dimer. In this study, we
demonstrate that a 10-nucleotide palindromic sequence (pal) located at the 3 end of the  encapsidation signal is
critical for human immunodeficiency virus type 2 (HIV-2) replication and affects genomic RNA encapsidation. We
used short-term and long-term culture of pal-mutated viruses in permissive C8166 cells and their phenotypic
reversion to show the existence of a structurally extended SL1 during HIV-2 replication, formed by the interaction
of the 3 end of the pal within  with a motif located downstream of SL1. The stem extending HIV-2 SL1 is
structurally similar to stem B described for HIV-1 SL1. Despite the high degree of phylogenetic conservation, these
results show that mutant viruses are viable when the autocomplementary nature of the pal sequence is disrupted,
but not without a stable stem B. Our observations show that formation of the extended SL1 is necessary during viral
replication and positively affects HIV-2 genomic RNA encapsidation. Sequestration of part of the packaging signal
into SL1 may be a means of regulating its presentation during the replication cycle.
The 5-untranslated regions of retroviral RNAs contain several
structured motifs that are involved in various steps in viral repli-
cation, including transcriptional transactivation, splicing, encapsi-
dation, dimerization, and initiation of reverse transcription (for a
review, see reference 3). Encapsidation of the genomic RNA in
lentiviruses is a very specific process. Two molecules of unspliced
RNA are selected for encapsidation over a vast excess of different
spliced viral RNA species and cellular RNA. The historical model
of retroviral RNA encapsidation has been that viral structural
proteins like Gag recognize and bind specific RNA motifs
located downstream of the major splice donor site, and thus
only present in the unspliced viral RNA, and transfer a pair
of these molecules into one newly forming viral particle (for
a review, see references 11 and 20).
However, most recent studies suggest that the encapsidation
signal is not limited to a single RNA element. The human immu-
nodeficiency virus type 1 (HIV-1) encapsidation signal is multi-
partite, with structural elements located across the 5-untrans-
lated and Gag-encoding regions (4, 6, 31). Similarly, HIV-2 and
simian immunodeficiency virus (SIV) RNA encapsidation motifs
have been localized either downstream of the major splice donor
site (38), upstream (16, 32, 39, 46), or both (1, 37).
A hallmark of retroviral RNA encapsidation is that two mole-
cules of genomic RNA are encapsidated per viral particle (for a
review, see references 14, 34, and 41). Gentle extraction and
deproteinization of virions revealed that the two encapsidated
RNA molecules form a dimer through noncovalent RNA-RNA
interactions (28). Electron microscopy studies with increasing de-
naturation identified the 5 ends of the genomic RNA molecules
as the location of the strongest RNA-RNA interaction in dimers
isolated from viral particles; this interaction was named the dimer
linkage structure (see reference 2 for the original study and ref-
erence 19 for a study with HIV-1). In HIV-1, a strong candi-
date involved in the formation of the dimer linkage struc-
ture was identified in vitro upstream of the major splice
donor site. This element was named the dimerization initi-
ation site or stem-loop 1 (SL1) (18, 25, 33, 35, 45). Besides
its role in genomic RNA dimerization, the SL1 sequence
was shown to be involved in other stages of HIV-1 replica-
tion, notably encapsidation (see Table 1 in reference 34).
We previously presented evidence that the  encapsidation
signal interferes with SL1-mediated HIV-2 RNA dimerization
in vitro (23). The sequence responsible is a 10-nucleotide (nt)
palindromic sequence (pal) located at the 3 end of . The pal
motif was also shown to mediate RNA dimerization upon
binding of an antisense oligonucleotide directed against SL1
(23). We and others showed that the dimerization of HIV-2
leader RNA is regulated in vitro by a long-distance intramo-
lecular interaction between nucleotides located at the 5 end of
U5 and nucleotides encompassing the gag translation initiation
site (10, 24). Thus, several short- and long-distance interactions
influence the presentation of the -SL1 region in HIV-2 leader
RNA in vitro.
Since the pal motif is located within the  encapsidation
signal, is phylogenetically conserved (see Discussion), and can
influence dimerization of HIV-2 leader RNA fragments in
vitro, we have analyzed in this study the function of HIV-2 pal
during replication in permissive C8166 cells. We also used
long-term culture of defective viruses and their phenotypic
reversion to gain insight into the necessity of the palindromic
sequence and functionally important secondary structure in-
teractions. In particular, we show that the defects in viral
replication for some pal-mutated viruses can be compensated
for by nucleotide changes in or close to the mutated pal ele-
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ment. Our results provide evidence for the existence of a struc-
turally extended SL1 during HIV-2 replication, formed by the
interaction of the 3 end of the 10-nt pal element in  with a
motif located downstream of SL1. Our observations also sug-
gest that formation of the extended SL1 during viral replica-
tion positively affects HIV-2 genomic RNA encapsidation, al-
though a palindromic sequence is not strictly required for viral
viability.
MATERIALS AND METHODS
Plasmid construction. To engineer mutations in the 5-untranslated region, we
used a plasmid derived from a modified pROD10 plasmid containing full-length
HIV-2 ROD (17, 42). The modified plasmid pROD10 was provided by the EU
Programme EVA/MRC Centralised Facility for AIDS Reagents, NIBSC, United
Kingdom. The AatII-XhoI fragment from modified pROD10 digestion was
subcloned into pGEM7-Zf (Promega). This plasmid contains the 5 long
terminal repeat and most of the gag coding region (Fig. 1) (22). The num-
bering is based on the genomic RNA sequence of an HIV-2 ROD isolate
(GenBank accession no. M15390). Most mutations were introduced using a
QuikChange II XL site-directed mutagenesis kit (Stratagene) and the appro-
priate primers. The reversion-associated mutations in the -SL1 region were
introduced using a QuikChange II XL kit with plasmids bearing the original
mutations. The AatII-XhoI fragments of plasmids bearing the mutations were
then reinserted in the modified pROD10 backbone. All constructs were
checked by DNA sequencing.
Cell culture and transfection. COS-7 cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum, penicillin,
and streptomycin (Invitrogen). Transient transfection of COS-7 cells was per-
formed using a Trans-IT-COS transfection kit (Mirus). Cells and medium were
harvested at 2 days posttransfection. HIV-2 capsid protein levels in the medium
FIG. 1. 5 leader region of HIV-2 ROD genomic RNA and mutations in the encapsidation domain. (A) The landmark sequences with known
functions are indicated by boxes, with their names indicated above. TAR, polyA signal, PBS, , SL1, SD, and gag represent the transactivation
region, the poly(A) signal domain, the primer binding site, the encapsidation signal, stem-loop 1, the major splice donor site, and the 5 end of
the Gag protein coding region, respectively. The secondary structure of nucleotides 380 to 444 is represented, with gray boxes highlighting the 10-nt
palindromic sequence pal and the 6-nt palindromic sequence in the loop of the SL1 element. The short thick line below nt 380 to 408 represents
the encapsidation signal  characterized in cell culture (15). (B) Replication kinetics of wild-type (open squares), -negative (open triangles), and
pal-negative (closed circles) viruses in C8166 cells. DNA plasmids were transfected into COS-7 cells, and viruses were isolated from the
supernatant. A standardized amount of viral particles (10 ng of p27 capsid, as determined by ELISA) was used to infect permissive C8166 cells.
Aliquots of supernatants were then assayed for reverse transcriptase activity. (C) (Top) Sequences of the wild-type and scrambled pal 392-401
regions for the clones used in this experiment. SCR1 was designed to both destroy the palindrome and disrupt a proposed -SL1 interaction (23,
24). SCR2 is the complementary sequence to SCR1. The nucleotides different from the wild-type sequence are represented with lowercase letters.
(Bottom) Replication kinetics of wild-type (open squares), SCR1 (open triangles), and SCR2 (closed circles) pal viruses in C8166 cells. DNA
plasmids were transfected into COS-7 cells, and viruses were isolated from the supernatant. A standardized amount of viral particles (10 ng of p27
capsid, as determined by ELISA) was used to infect permissive C8166 cells. Aliquots of supernatants were then assayed for p27 capsid by ELISA.
(D) (Top) Sequences of the wild-type and mutated pal 392-401 regions for the clones used in this experiment. Weak and strong pal sequences were
chosen from in vitro studies in which they were shown to form weaker and stronger RNA-RNA duplexes, respectively, than the wild-type sequence
(36). (Bottom) Replication kinetics of wild-type (open squares), weak (open triangles), and strong (closed circles) pal viruses in C8166 cells. Viral
replication was followed as described for panel C.
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were quantified by a p27-specific enzyme-linked immunosorbent assay (SIV p27
ELISA; Zeptometrix). The infectivity of viruses in the medium was quantified
using P4-CCR5 indicator cells. This cell line expresses the CD4 and CCR5
receptors and contains a beta-galactosidase gene under the control of the HIV
long terminal repeat, thus detecting synthesis of the transactivating Tat protein
after productive infection of the cells by the input viruses (5). After 2 days of
culture postinfection, the cells were stained for beta-galactosidase activity, and
the blue infected cells were counted. The numbers were then normalized first to
the amounts of input viruses, as determined by reverse transcriptase activities,
and second to the level of infection by wild-type (wt) virus to give the infectivities
of viruses relative to the wild type.
Cell culture and infection. C8166 cells (NIH AIDS reagent 404) were main-
tained in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented
with 10% fetal calf serum, penicillin, streptomycin, and glutamine (Invitrogen).
Medium from transfected COS-7 cells containing 10 ng of HIV-2 p27 capsid
protein, as determined by ELISA, was used to infect 2  104 C8166 cells. This
corresponds to a multiplicity of infection of 0.01 for the wild-type virus, as
determined with P4-CCR5 indicator cells (data not shown). After 12 h, cells were
washed twice and resuspended in RPMI medium-fetal calf serum. An aliquot of
medium was then taken and served as a reference (p27 ELISA). Aliquots of
medium were taken daily and spun to remove cells, and the supernatants were
frozen at 80°C. Viral replication was followed for 1 or 2 weeks by quantifying
the level of either CAp27 protein or reverse transcriptase activity in the super-
natant. The CAp27 protein concentration was determined by enzyme-linked
immunosorbent assay (Zeptometrix). The level of reverse transcriptase activity
was quantified using the Amersham Biosciences Quan-T-RT assay system.
RNA isolation and analysis. The total cellular RNA and the extracellular viral
RNA fractions were purified using a Stratagene Absolutely RNA RT-PCR mini-
prep kit. To pellet the viral particles, a fraction of the medium was centrifuged
for 2 hours at 4°C and 12,000 rpm. Purified RNAs were used for reverse tran-
scription-PCR (AccuScript high-fidelity RT-PCR system; Stratagene) or an
RNase protection assay (RPA III; Ambion), as described by the manufacturer.
Briefly, the RNase protection assay was done using an antisense RNA probe
complementary to the region of positions 401 to 562 of the HIV-2 ROD isolate.
The antisense region was cloned into the pGEM7Zf() vector (Novagen) so that
the T7 transcript had around 45 nucleotides of vector at its 5 end. The non-
HIV-2 tail of the probe was used as a marker of the RNase’s digestion efficiency
during the RNase protection experiment. Up to two protected bands were
expected, with a 162-nt band corresponding to the 5 end of the unspliced
genomic RNA and a 70-nt band corresponding to any spliced HIV-2 RNAs (see
Fig. 3B). Furthermore, targeting of the region of positions 401 to 562 gives the
same profile with wild-type or pal-mutated viral RNAs.
RESULTS
Identification of a conserved 10-nucleotide palindromic
sequence in the core  region of HIV-2 leader RNA. The
region located upstream of the HIV-2 SL1 element is able to
influence the SL1-mediated dimerization of leader RNA
fragments in vitro (23). We therefore wanted to assess its
functional importance in HIV-2 replication in cell culture.
We deleted the 10-nt palindromic sequence (pal) located
upstream of SL1 and in the downstream part of the encap-
sidation signal  characterized by Lever and colleagues (Fig.
1A) (15). Infection of permissive C8166 cells by both -neg-
ative and pal-negative mutants did not lead to productive
infection, suggesting that an important functional element
overlaps with the 10-nt palindromic sequence (Fig. 1B).
Since deletion of the 10-nt pal greatly affected viral rep-
lication, we then analyzed the effects of substitutions that
destroy the palindromic nature of the pal element on viral
replication (Fig. 1C). Despite robust virus production after
transfection in COS-7 cells (data not shown), SCR1 and
SCR2 mutants were defective for replication in permissive
C8166 cells (Fig. 1C).
We chose to further test whether the palindromic nature of
pal may play a role in virus replication in cell culture. We
constructed two substitution mutants (Fig. 1D) that we call
strong pal (5-GGGCUGGCCC-3) and weak pal (5-GGGA
GUUCCC-3). These sequences have been shown to form
stronger or weaker RNA-RNA duplexes (compared to the wt
sequence) in vitro (36). Infection of permissive C8166 cells by
strong and weak pal mutant viruses did not lead to productive
FIG. 2. Two nucleotide changes that appeared during long-term culture are solely able to restore viral replication in alternative (pal) viruses.
(A) (Top) Sequences of the wild-type, weak, and weak G394A/T397C mutant pal 392-401 regions for the clones used in this experiment. The
reversion-associated mutations are boxed, and nucleotides different from the wild-type sequence are shown with lowercase letters. (Bottom)
Replication kinetics of wild-type (open squares), weak (open triangles), and weak G394A/T397C mutant (closed circles) pal viruses in C8166 cells.
Viral replication was followed as described in the legend to Fig. 1B. (B) (Top) Sequences of the wild-type and mutated pal 392-401 regions for
the clones used in this experiment. (Bottom) Replication kinetics of wild-type (open squares), strong (closed diamonds), strong G394A mutant
(closed triangles), strong C400T mutant (open circles), and strong G394A/C400T mutant (closed circles) pal viruses in C8166 cells. Viral
replication was followed as described in the legend to Fig. 1B.
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infections relative to wild-type infections, with weak pal and
strong pal viruses showing low or no virus production (Fig.
1D). These results indicate that the palindromic nature of pal
is perhaps less important than its primary sequence for HIV-2
replication in cell culture.
Phenotypic reversion of alternative pal mutants in long-
term culture. In order to see if the replication of the defective
viruses could be enhanced by virus-induced mutations, dupli-
cates of the SCR2, strong, and weak pal virus cultures shown in
Fig. 1C and 1D were passaged for several months. During the
first several weeks of culture, no cytopathic effects were ob-
served for any of the viruses. However, cell death and syncytia
were observed at around 8 weeks postinfection for the weak
pal cultures and at week 14 for one of the strong pal cultures.
The supernatants of these three cultures tested positive for
both reverse transcriptase activity and the presence of the p27
capsid antigen. However, the SCR2 pal cultures never reverted,
and neither viral proteins nor viral RNA or DNA could be
detected outside or inside the cells after 8 months of culture
(data not shown).
Aliquots of infected cells were harvested at week 15 postin-
fection, and the region corresponding to the leader of the
genomic RNA was sequenced after RT-PCR to check the
sequence variability in the pool of infected cells for each cul-
ture (Table 1). Aliquots of supernatants were also harvested at
week 26 and processed similarly. Despite the presence of T310
in all of the original plasmid DNAs, all sequences showed a
majority of T310C nucleotide changes in the primer-binding
site after extended culture (data not shown), which indicates
that a tRNA3
Lys molecule was used as the primer for reverse
transcription, rather than tRNA5
Lys (8).
Interestingly, the other nucleotide changes in the 5-untrans-
lated region were located in or close to the mutated pal region.
One reversion to a wild-type nucleotide was seen in all clones:
the mutation A394G in the pal domain reverted back to A394
(Table 1). Two other nucleotide changes were seen in or down-
stream of the mutated pal region: C400 changed to T400 for
the strong pal culture by week 15, and a partial or total change
of G442 to A442 occurred in the weak pal cultures between
weeks 15 and 26 (Table 1).
Effects of reversion-associated mutations in the weak and
strong pal regions on viral replication. To test if the muta-
tions we observed in the mutated pal regions of the pheno-
typically reverted clones were solely responsible for the re-
FIG. 3. Infectivity and genomic RNA encapsidation are affected by alternative (pal) mutations and restored through reversion-associated
mutations. (A) Single-round infectivity assay with P4-CCR5 reporter cells of viruses produced by transfected COS-7 cells. The mutated viruses used
in this experiment are shown in Fig. 2. The infectivity assay is described in Materials and Methods. The error bars represent the standard deviations
for duplicate experiments. (B) (Top) RNase protection assay of wild-type (lanes 4), weak (lanes 5), and weak G394A/T397C mutant (lanes 6) pal
viruses. The controls were the undigested probe (lane 1) and the digested probe used with in vitro RNA transcript 1-470 (lane 2) or 1-561 (lane
3). (Bottom) Diagram of the radioactive antisense probe used in this experiment and the expected protected fragments. (C) Encapsidation yields
of different pal-mutated viruses. The amounts of unspliced genomic RNA in viruses isolated from the medium of transfected COS-7 cells were
quantified using an RNase protection assay. The numbers were then normalized first to the amount of viruses in the medium, as determined by
p27 capsid ELISA, and second to the level of encapsidation by wild-type viruses, set at 100%, to give the encapsidation relative to that of the wild
type. The error bars represent the standard deviations for two or three experiments.
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versions, we cloned these changes into the original weak or
strong pal HIV-2 DNA backbone. We tested one of the
three different reversion-associated mutation sets identified
by the sequencing of individual clones, namely, two nucleo-
tide changes in the weak pal region (G394A and T397C)
(Table 1 and Fig. 2A). The medium from the resulting
COS-7 transfection was used to infect C8166 cells, using a
constant amount of p27 capsid, as measured by ELISA. The
two nucleotide changes in the weak pal domain (G394A and
T397C) increased the levels of viral replication of the mu-
tated weak pal viruses to close to the wild-type level (Fig.
2A). This conclusion held true for the two nucleotide
changes in the strong pal domain, i.e., G394A and C400T
(Table 1 and Fig. 2B). The changes increased the level of
viral replication of the strong pal G394A/C400T virus to
close to the wild-type level (Fig. 2B). Interestingly, none of
the single changes was able to compensate for the defective
replication of strong pal viruses (Fig. 2B). Only when the
G394A and C400T nucleotide changes were present in the
same genomic RNA were the mutated viruses able to rep-
licate at or close to the wild-type level (Fig. 2B). Thus, two
nucleotide changes in the weak and strong pal domains were
able to restore viral replication efficiency.
Effects of reversion-associated mutations in the weak and
strong pal regions on genomic RNA encapsidation. We then
sought to identify the stage(s) of HIV-2 replication in C8166
cells responsible for the low replication levels of the weak
and strong pal viruses and for the wt level of the weak and
strong pal viruses containing the two reversion-associated
nucleotide changes, i.e., G394A/T397C and G394A/C400T,
respectively (Fig. 2). First, the phenotypes observed in
C8166 cell cultures were also observed when the viruses
were tested on P4-CCR5 reporter cells (Fig. 3A), under-
scoring the gravity of the defect(s). Second, we used an
RNase protection assay to detect the level of genomic RNA
encapsidation, since the pal element is located in a se-
quence, , that has been shown to play an important role in
encapsidation (15). The encapsidation of -negative and
pal-negative genomic RNAs was similarly decreased three-
fold relative to the wt level (Fig. 3C). Indeed, the encapsi-
dation level of weak pal genomic RNA in COS-7-produced
virions was also decreased two- to threefold (Fig. 3B and C).
Importantly, the genomic RNA encapsidation level for the
weak pal G394A/T397C virus was at or close to the wild-type
level (Fig. 3B and C). Similar results were found for the
strong pal and strong pal G394A/C400T viruses (Fig. 3C).
The single changes (G394A or C400T) partially increased
the encapsidation levels of the corresponding genomic RNA
molecules, suggesting a cumulative effect of both nucleotide
changes when present in the same genomic RNA (Fig. 3C).
Thus, two nucleotide changes in the weak and strong pal
domains were able to compensate for the drop in genomic
RNA encapsidation.
DISCUSSION
An impetus for this study was derived from prior in vitro
studies of functional interactions in the HIV-2 leader RNA.
We and others showed evidence that several short- and long-
distance interactions in the HIV-2 leader RNA influence the
presentation of the SL1 dimerization element in vitro (10, 24).
Secondary structure prediction suggested a base-pairing inter-
action between the 5 end of SL1 and a sequence immediately
upstream, which could be responsible for the functional silenc-
ing of SL1-mediated leader RNA dimerization (24). The na-
ture of this silencer sequence was interesting for two reasons.
First, it is located in the downstream part of the encapsidation
signal  characterized by Lever and colleagues (15). Second, it
is a 10-nt palindromic (or autocomplementary) sequence
which is phylogenetically conserved in HIV-2 and macaque
and sooty mangabey SIVs (27).
In this work, we used long-term culture of defective viruses
and their phenotypic reversion to study the functional impor-
tance of the 10-nt  pal in HIV-2 replication. In particular, we
showed that the defects in viral replication for some pal-mu-
tated viruses could be compensated for by two nucleotide
changes in or close to the mutated pal element. The simplest
way to explain the reversion results is to suppose that the 3
end of the pal element is involved in an extended stem-loop 1
structure. Furthermore, characterization of the mutant viruses
suggests that the formation of this extended structure is nec-
essary for HIV-2 replication and affects genomic RNA encap-
sidation. The results also suggest that the 5 end of the pal
element plays a related but independent function to that of the
3 end in viral replication and encapsidation. Furthermore, the
fact that pal-mutated viruses lacking a functional palindromic
sequence can replicate as well as wild-type pal viruses in C8166
cells suggests that the conservation of the pal element may be
due more to its role in the formation of an extended stem-loop
1 structure than to a strict requirement for a palindrome.
The experiments presented here suggest a model for an
essential function of the 3 end of the pal element (GCUCC-3)
in the formation of a stem with a 5-GGAGC element located
downstream of SL1. We call the new stem extending the SL1
structure “stem B” because of its homology to that described
for HIV-1 isolates (Fig. 4) (26, 43, 44). Indeed, the extended
SL1 structure in HIV-2 was first proposed based on observed
encapsidation and viral replication defects when larger dele-
tions were made in the -SL1 region (32). Recent computa-
TABLE 1. Changes in the -SL1 region occurring during long-term
culture of strong and weak pal-defective viruses
Virus Time ofculture (wk)
Nucleotide at indicated position
394 397 400 442
Wild type A G C G
Strong pal 1a 0 G G C G
15 G  Ab G T G
26 A G T G
Weak pal 1 0 G T C G
15 A T C G
26 A T  Cb,c C G  Ab,c
Weak pal 2 0 G T C G
15 A T C A  Gb
26 A T C A  Gb
a The strong pal 2 culture never reverted.
b The proportion of each nucleotide was estimated according to the areas of
the peaks of corresponding nucleotides on the sequencing electropherogram.
c Twenty-two individual clones were sequenced. Among these 22 clones, the
distribution of pairs at positions 397 and 442 was as follows: TG  2, TA  16,
CG  4, and CA  0.
VOL. 81, 2007 STRUCTURE OF HIV-2 ENCAPSIDATION ELEMENT 3289
tional (21) and biochemical (7) analyses of the structure of the
HIV-1 leader region further supported the existence of the
stem B structure in SL1. Phylogenetic data provide evidence
for the existence and conservation of stem B in HIV-1 (7, 21)
and HIV-2 (Fig. 4D) (27).
The formation of stem B is an important step in HIV-2
replication. A less stable or nonexistent stem leads to a very
low level of replication (Table 2) (G values for wild-type,
weak, and strong pal stems were 7.9, 3.7, and 4.1 kcal/
mol, respectively), and genomic RNA encapsidation appears
to be one of the stages affected by mutations in this region (Fig.
3C). The stem B-stabilizing reversion-associated mutations oc-
curred at both wild-type nucleotides (Table 1) (strong pal
C400T and weak pal G442A mutants) and at one originally
mutated nucleotide (Table 1) (weak pal T397C mutant). The
strong pal C400T reversion exchanged a CA for a UA base
pair, increasing the stem stability from 4.1 to 8.3 (Fig. 4B
and Table 2), while the weak pal T397C reversion replaced a
wobble UG with a CG base pair, increasing the stem B stability
from 3.7 to 6.2 (Fig. 4C and Table 2).
FIG. 4. Secondary structure models of extended SL1 and stem B structures described in this work. (A) The HIV-2 ROD isolate (GenBank
accession no. M15390) SL1 structure is represented with another stem structure that base pairs with the 3 end of the pal element with a
5-GGAG-containing motif located immediately downstream of the short SL1 structure. We chose the names stem B and stems C1 and C2 to
describe the extended HIV-2 SL1 in comparison with the structure of the HIV-1 SL1 element, as described by Laughrea and colleagues (26).
(B) Mutations in the pal elements of strong pal viruses disrupt stem B (left structure). An alternative, more stable base pairing is possible by a
one-nucleotide shift with a single mismatch in the middle (middle structure). The reversion-associated mutation C400T stabilizes the alternative
stem B, and the G394A mutation restores a partial GGA motif (right structure). (C) Mutations in the pal elements of weak pal viruses decrease
the stability of stem B (left structure). The reversion-associated mutation T397C or G442A stabilizes the mutated stem B by restoring Watson-Crick
base pairing, while G394A reversion restores a partial GGA motif (right structure). The reversion-associated mutations are boxed, and nucleotides
different from the wild-type sequence are shown with lowercase letters. (D) The consensus stem B structure from the analysis of 37 HIV-2 and
SIV sequences from the HIV Sequence Compendium 2005 is indicated, with the proportions of alternative base pairs shown to the right (27).
(E) Secondary structure model of HIV-1 SL1 from the HxB2 isolate (GenBank accession no. K03455). The stems are named according to
reference 26.
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The importance of the 5 end of the pal element is under-
scored by several points. First, most, but not all, pal-mutated
viruses with wt stability for stem B replicated at wt levels
(compare Fig. 1 and 2 to Table 2). Second, strong pal viruses
bearing the single C400T change have a stem B stability similar
to that of the wt, but they did not replicate in C8166 cells. They
showed an increased encapsidation level relative to the strong
pal parent, but it was lower than the wt level (compare Fig. 2B
and 3C and Table 2). Lastly, all of the phenotypically reverted
viruses showed reversion of the G394 nucleotide back to the
wild-type A394 nucleotide (Table 1). We hypothesize that the
5 end of pal (5-GGAG motif) is a purine-rich Gag polypro-
tein recognition element, which could be functionally related
to the 5-GGAG in HIV-1 SL3 (9). Indeed, purine-rich ele-
ments have a long history in retroviral RNA encapsidation and
dimerization research (for example, see references 30 and 47),
although their exact mode of action is not completely under-
stood. In HIV-1, the purine-rich motifs in or downstream of
SL3 play an important role in dimerization and encapsidation
of the genomic RNA (40).
Remarkably, the phenotypic reversions we observed in our
long-term culture experiments show that mutant viruses are
viable without a palindromic sequence (compare Fig. 2 and
Table 2), but it is not known if the mutated viruses would be
viable in animal infections in vivo. The palindromic nature of
pal is conserved in HIV-2 and SIV: 31 of 37 sequences exam-
ined show a T396-containing pal, whereas 6 sequences show an
A396-containing pal (Fig. 4D) (27). The A396-containing pal
isolates belong to HIV-2 type AB or B or SIVSMM (27). The
presence of A396, while setting up an AG base pair, is not at
odds with the stem B model, as AG base pairs are frequently
found at the ends of helices, where they form “conformation-
ally unique helix extensions” (12). Indeed, it is possible that an
A396-containing stem B could be slightly more stable than a
U396-containing stem B, since the UG base pair in stem B is
identified as a class B, “unstacked” pair which may not even
base pair and, if it does, is probably not in a wobble confor-
mation (13).
Although we cannot rule out that a pal-pal interaction be-
tween two HIV-2 RNA molecules exists transiently during viral
replication, we now view the palindromic nature of pal as a
fortuitous event in relation to the functions it fulfills: its 5-
GGAG(U) motif is likely to be a Gag polyprotein binding
motif, while its GCUCC-3 motif base pairs with another 5-
GGAG(C) motif downstream of SL1 to form stem B (Fig. 4A).
The stem B of HIV-1 SL1 is also formed by a similar interac-
tion between CUCG-3 and 5-CGAG motifs (compare stems
B in Fig. 4A and E).
Finally, the finding of stem B extending the SL1 structure in
HIV-2 genomic RNA brings both answers and exciting ques-
tions. The next endeavor will be to test if HIV-2 stem B is also
involved in genomic RNA dimerization and reverse transcrip-
tion, two functions that are naturally linked to this region (44).
It will be equally intriguing to ascertain whether the formation
of the extended SL1 during HIV-2 replication affects (or is
affected by) the translation of the gag gene, since the absence
or presence of the long-distance interaction involving the gag
initiation codon seems to influence the presentation of the
pal-SL1 domain in vitro (10, 24).
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